Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > ACCL > Summary

Accelrys Inc.
(ACCL)

6.01USD   Down 0.01 (0.17%)   
At 2:30AM IST
 Accelrys Inc. (NGM:ACCL) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 6.01USD
Trade Time:2:30AM IST
Change:Down 0.01 (0.17%) 
Prev Close:6.02
Open:6.08
Bid:5.51 x 100
Ask:6.68 x 100
1y Target Est:6.00
Day's Range:6.00 - 6.17
52wk Range:3.05 - 6.28
Volume:76,735
Avg Vol (3m):101,881
Market Cap:165.64M
P/E (ttm):120.20
EPS (ttm):0.05
Div & Yield:N/A (N/A%)
Add ACCL to Portfolio   Download Data

HEADLINES

 
•ACCELRYS, INC. Files SEC form 10-Q, Quarterly Report - EDGAR Online  - Wed 2:49AM
•New Star Analyst Rankings for Accelrys, Inc. - StarMine  - Sat, Feb 6
•ACCELRYS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - EDGAR Online  - Fri, Feb 5
•Accelrys Announces Third Quarter Fiscal Year 2010 Financial Results - Business Wire  - Fri, Feb 5
•Accelrys to Showcase Integrated Informatics, Modeling and Simulation Solutions at the Molecular Medicine Tri-Conference - Marketwire  - Fri, Jan 29
•Accelrys Announces Date of Third Quarter Fiscal 2010 Financial Results and Conference Call - Business Wire  - Fri, Jan 29
•Accelrys to Showcase New Biotherapeutics Research Tools in Discovery Studio(R) at CHI's PepTalk 2010 Conference - Marketwire  - Fri, Jan 8
•ACCELRYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic - EDGAR Online  - Wed, Jan 6
•Accelrys Further Strengthens Management Team with Two Experienced Executives - Business Wire  - Wed, Jan 6
•Accelrys to Showcase Materials Studio 5.0 at MRS (Materials Research Society) Fall Meeting - Marketwire  - Tue, Nov 24
» More Headlines for ACCL...

ANALYST

 
EPS Est (next year) (Mar-10) :0.25
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:2.0
PEG Ratio:0.86
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Accelrys, Inc. engages in the design, development, marketing, and support of software based solutions that facilitate the discovery and development of products and processes in the pharmaceutical, biotechnology, energy, chemical, aerospace and def...

» Full Company Profile